(Q54098852)

24 May 2018

title

In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. (English)

1 reference

24 May 2018

1 reference

1 reference

1 reference

J Dubois

1

1 reference

24 May 2018

C St-Pierre

series ordinal

2

1 reference

24 May 2018

publication date

1 April 1999

1 reference

24 May 2018

Diagnostic Microbiology and Infectious Disease

published in

1 reference

24 May 2018

volume

33

1 reference

24 May 2018

issue

4

1 reference

24 May 2018

page(s)

261-265

1 reference

24 May 2018

Prevalence of legionellosis among adults: a study of community-acquired pneumonia in France

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

Microbial etiology of acute pneumonia in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

Prevalence of Legionnaires' disease in pneumonia patients admitted to a Danish department of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

From fluoroquinolones to 2-pyridones

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

Legionnaires' Disease: Clinical Features of the Epidemic in Philadelphia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900150-3

7 January 2021

10.1016/S0732-8893(98)00150-3

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018